TACR1 and type 2 diabetes mellitus: Having documented the presence of structural and functional nociceptive alterations in the BM of patients with type 2 diabetes, we next conducted immunofluorescence and flow cytometry analyses of CD34+ HSPCs, which co-express the SP receptor NK1R.